Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting.
| Author | |
|---|---|
| Abstract |
:
The most commonly used noninvasive test for colorectal cancer (CRC) screening has been the guaiac fecal occult blood test (gFOBT). The fecal immunochemical test (FIT) detects CRC and colorectal polyps with higher levels of sensitivity than the gFOBT, and may be more acceptable to patients. However, the FIT has not replaced the gFOBT in many clinical settings. We analyzed data from a large healthcare system that replaced the gFOBT with the FIT to determine the effects on CRC screening. |
| Year of Publication |
:
2017
|
| Journal |
:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
|
| Volume |
:
15
|
| Issue |
:
8
|
| Number of Pages |
:
1265-1270.e1
|
| ISSN Number |
:
1542-3565
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(17)30133-7
|
| DOI |
:
10.1016/j.cgh.2017.01.025
|
| Short Title |
:
Clin Gastroenterol Hepatol
|
| Download citation |
